CKS2 and retinoblastoma: By screening a set of cancer-related genes directly regulated by transcription factor E2F1 and a series of experimental validations, we demonstrated that E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in RB and CKS2 may serve as a potential therapeutic target for retinoblastoma.